BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Curis
CRIS
$9.78M
| $467K | ﹤0.01% |
3,384
+710
| +27% | +$177K |
|
4152
Myomo
MYO
$39M
| $467K | ﹤0.01% |
145,422
+111,089
| +324% | +$377K |
|
4153
RF Industries
RFIL
$134M
| $464K | ﹤0.01% |
132,820
-7,571
| -5% | -$23.5K |
|
4154
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
| $462K | ﹤0.01% |
16,822
+16,806
| +105,038% | +$464K |
|
4155
Cytosorbents Corp
CTSO
$22.7M
| $461K | ﹤0.01% |
655,805
-66,630
| -9% | -$57.8K |
|
4156
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $459K | ﹤0.01% |
9,280
+1,540
| +20% | +$76.6K |
|
|
KLRS
4157
Kalaris Therapeutics
KLRS
$83.5M
| $459K | ﹤0.01% |
27,566
-119,644
| -81% | -$2.11M |
|
4158
Loop Industries
LOOP
$35.3M
| $456K | ﹤0.01% |
218,236
+887
| +0.4% | +$2.36K |
|
|
ICAD
4159
DELISTED
iCAD Inc
ICAD
| $455K | ﹤0.01% |
349,973
-2,549
| -0.7% | -$3.92K |
|
|
LFT
4160
Lument Finance Trust
LFT
$34.6M
| $445K | ﹤0.01% |
185,493
+369
| +0.2% | +$899 |
|
|
FLNT
4161
Fluent
FLNT
$102M
| $444K | ﹤0.01% |
122,892
+6,938
| +6% | +$23.2K |
|
|
OKUR
4162
OnKure Therapeutics
OKUR
$154M
| $443K | ﹤0.01% |
29,365
-70,001
| -70% | -$1.19M |
|
4163
CuriosityStream
CURI
$145M
| $441K | ﹤0.01% |
386,496
+20,208
| +6% | +$22.4K |
|
4164
Blue Ridge Bankshares
BRBS
$315M
| $440K | ﹤0.01% |
168,577
-974,682
| -85% | -$2.72M |
|
4165
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
| $438K | ﹤0.01% |
1,753
| – | – |
|
|
CKPT
4166
DELISTED
Checkpoint Therapeutics
CKPT
| $436K | ﹤0.01% |
202,860
+37,416
| +23% | +$66.6K |
|
4167
IAMGOLD
IAG
$8.2B
| $435K | ﹤0.01% |
116,097
-1,059
| -0.9% | -$4.04K |
|
4168
Vanguard Financials ETF
VFH
$13.5B
| $434K | ﹤0.01% |
4,350
| – | – |
|
|
DZSI
4169
DELISTED
DZS Inc. Common Stock
DZSI
| $433K | ﹤0.01% |
370,327
-1,026,963
| -73% | -$1.4M |
|
4170
Acme United Corp
ACU
$217M
| $433K | ﹤0.01% |
12,340
+1,166
| +10% | +$46K |
|
4171
Vanguard Real Estate ETF
VNQ
$39.2B
| $429K | ﹤0.01% |
5,120
-40
| -0.8% | -$3.3K |
|
4172
Rapid Micro Biosystems
RPID
$106M
| $428K | ﹤0.01% |
648,519
-371,209
| -36% | -$317K |
|
|
NEUE
4173
DELISTED
NeueHealth
NEUE
| $428K | ﹤0.01% |
78,650
+6,037
| +8% | +$35.9K |
|
4174
Rallybio
RLYB
$84.5M
| $423K | ﹤0.01% |
39,453
-170,043
| -81% | -$2.3M |
|
4175
Telomir Pharmaceuticals
TELO
$83.2M
| $423K | ﹤0.01% |
+87,899
| New | +$548K |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.